Biotech | October 31, 2023
Aragen setting up a US$ 30 million bio-manufacturing site in Bengaluru
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Approval based on DESTINY-Lung02 results where AstraZeneca and Daiichi Sankyo’s Enhertu demonstrated a confirmed objective response rate of 49% and median duration of response of 16.8 months in previously treated patients
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Lupin enters into BTA with Lupin Manufacturing Solutions
Lokavant provides clinical trial intelligence
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The companies will work with investigators to share the results with the scientific community
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Subscribe To Our Newsletter & Stay Updated
